J. Boiziau

发表

Discovery of the first non-ATP competitive IGF-1R kinase inhibitors: advantages in comparison with competitive inhibitors.

C. Venot, H. Strobel, D. Lesuisse, 2011, Bioorganic & medicinal chemistry letters.

Low molecular weight, sequence based, collagenase inhibitors selectively block the interaction between collagenase and TIMP (tissue inhibitor of metalloproteinases).

D. Faucher, J. Boiziau, Y. Lelièvre, 1990, Matrix.

Synthesis and Purification of Active Human Tissue Plasminogen Activator From Escherichia coli

P. Denéfle, J. Mayaux, P. Sarmientos, 1989, Bio/Technology.

Altered Patterns of Mucin Secretion in Gastric Hyperplasia in Mice

P. Greaves, J. Boiziau, J. -L. Boiziau, 1984, Veterinary pathology.

Inhibition of the EGF-stimulated cellular proliferation of ER 22 cells by hydroxybiphenyl derivatives.

B. Roques, B. Tocqué, C. Garbay, 1995, Journal of medicinal chemistry.

HIV-1 Aspartic Proteinase: High-Level Production and Automated Fluorometric Screening Assay of Inhibitors

B. Cambou, J. Mayaux, J. Boiziau, 1990 .

Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase: importance of additional hydrophobic aromatic interactions.

B. Roques, B. Tocqué, J. Le Pecq, 1994, Journal of medicinal chemistry.

Synthesis and structure-activity studies of a series of [(hydroxybenzyl)amino]salicylates as inhibitors of EGF receptor-associated tyrosine kinase activity.

B. Roques, B. Tocqué, R. Maroun, 1993, Journal of medicinal chemistry.

Synthesis and biological evaluation of a series of hydroxybenzylphenylamine derivatives as inhibitors of EGF receptor-associated tyrosine kinase activity.

B. Roques, B. Tocqué, C. Garbay, 1996, Anti-Cancer Drug Design.

Cloning of a Grb2 isoform with apoptotic properties.

B. Tocqué, F. Schweighoffer, M. Multon, 1994, Science.